Postmenopausal hormone therapy

British Medical Journal

Volumn 334, Issue 7599, 2007, Pages 860-861

  Grady, Deborah ^a   Barrett Connor, Elizabeth ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; ESTROGEN; GESTAGEN; HORMONE; PLACEBO;

BREAST CANCER; CANCER RISK; CLINICAL FEATURE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; DEMENTIA; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; EDITORIAL; FRAGILITY FRACTURE; HEALTH CARE PERSONNEL; HORMONAL THERAPY; HOT FLUSH; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL INFORMATION; MEDICAL SOCIETY; MENOPAUSAL SYNDROME; NONHUMAN; POST HOC ANALYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; STROKE; VAGINA ATROPHY; VENOUS THROMBOEMBOLISM; ESTROGEN THERAPY; FEMALE; METHODOLOGY; POSTMENOPAUSE;

ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; POSTMENOPAUSE;

EID: 34247880500     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj39185.380405.BE     Document Type: Editorial

References (9)

1. Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of the North American Menopause Society. Menopause 2007;14:1-17.
2. Nelson HD, Haney E, Humphrey L, Miller J, Nedrow A, Nicolaidis C, et al. Management of menopause-related symptoms. Evidence Report/Technol Assessment No 120. Rockville, MD: Agency for Healthcare Research and Quality, 2005. www.ahrq.gov/clinic/epcsums/menosum.htm.
3. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
4. Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The women's health initiative randomized controlled trial. JAMA 2004;291:1701-12.
5. Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women. JAMA 2004;291:2947-58.
6. Shumaker SA, Legault C, Thal L, Wallace RB, Ockene JK, Hendrix SL, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the women's health initiative memory study: a randomized controlled trial. JAMA 2003;289:2651-62.
7. Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007;297:1465-77.
8. National Institute for Health and Clinical Excellence. The guidelines manual. London: National Institute for Health and Clinical Excellence, 2006.
9. Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, et al. Current methods of the U.S. Preventive Services Task Force: a review of the process. Am J Prev Med 2001;20:21-35.